Circulating free DNA (cfDNA) and tissue next-generation sequencing analysis in a phase II study of infigratinib (BGJ398) for cholangiocarcinoma with FGFR2 fusions Meeting Abstract
| Authors: | Makawita, S.; Kelley, R. K.; Roychowdhury, S.; Weiss, K. H.; Abou-Alfa, G. K.; Macarulla, T.; Sadeghi, S.; Waldschmidt, D.; Zhu, A. X.; Goyal, L.; Yong, W. P.; Borbath, I.; El-Khoueiry, A. B.; Philip, P. A.; Moran, S.; Ye, Y.; Soifer, H. S.; Li, G.; Berman, C.; Javle, M. M. |
| Abstract Title: | Circulating free DNA (cfDNA) and tissue next-generation sequencing analysis in a phase II study of infigratinib (BGJ398) for cholangiocarcinoma with FGFR2 fusions |
| Meeting Title: | 2020 Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2020 Jan 23-25 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-02-01 |
| Language: | English |
| ACCESSION: | WOS:000530922700557 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.4_suppl.579 |
| Notes: | Meeting Abstract: 579 -- Source: Wos |
